Browsing: Ozempic
Less than a year ago, the head of Novo Nordisk A/S was fielding calls from “scared” food industry executives about his company’s…
People with a history of opioid abuse who took Novo Nordisk A/S’s Ozempic were less likely to overdose, according to…
A rare issue unites Americans across the political divide: the nation’s broken healthcare system, which is slowly killing its citizens.…
Women Taking Mounjaro And Zepbound Lose More Weight Than Men, New Study Suggests: What To Know
Topline Women with obesity and diabetes taking weight loss and diabetes drugs Mounjaro and Zepbound for over a year lost…
At least two in five U.S. adults — or more than 57 million people – under the age of 65…
Ozempic, the highly popular GLP-1 agonist drug touted by many celebrities for weight loss, is in short supply, according to…
Mars, the snack conglomerate behind M&Ms and Snickers, may have finally satisfied its sweet tooth. The company will acquire Pringles-maker…
Exclusive: The COO of Hims & Hers was the third person to try their GLP-1 drugs—and she’s ready to share her story
Melissa Baird, a health care executive based in Seattle knows first-hand the stigma around weight at work. “I struggled with…
InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. Venture capital funding reached…
Weight Loss Pills Intensify Obesity Drug Race—But Here’s Why Experts Say Injections Aren’t Going Anywhere
Topline Competition in the race to crack the lucrative weight loss drug market is heating up as rivals like Roche,…